Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 206

1.

Disparities in reported reasons for not initiating or stopping antiretroviral treatment among a diverse sample of persons living with HIV.

Johnson MO, Chesney MA, Neilands TB, Dilworth SE, Remien RH, Weinhardt LS, Wong FL, Morin SF; NIMH Healthy Living Project Team.

J Gen Intern Med. 2009 Feb;24(2):247-51. doi: 10.1007/s11606-008-0854-z. Epub 2008 Nov 18.

2.

Understanding Cross-Sectional Racial, Ethnic, and Gender Disparities in Antiretroviral Use and Viral Suppression Among HIV Patients in the United States.

Beer L, Mattson CL, Bradley H, Skarbinski J; Medical Monitoring Project.

Medicine (Baltimore). 2016 Mar;95(13):e3171. doi: 10.1097/MD.0000000000003171.

3.

Behavioral intervention improves treatment outcomes among HIV-infected individuals who have delayed, declined, or discontinued antiretroviral therapy: a randomized controlled trial of a novel intervention.

Gwadz M, Cleland CM, Applegate E, Belkin M, Gandhi M, Salomon N, Banfield A, Leonard N, Riedel M, Wolfe H, Pickens I, Bolger K, Bowens D, Perlman D, Mildvan D; Heart to Heart Collaborative Research Team.

AIDS Behav. 2015 Oct;19(10):1801-17. doi: 10.1007/s10461-015-1054-6.

4.

Antiretroviral therapy (ART) adherence and correlates to nonadherence among people on ART in Estonia.

Uusküla A, Laisaar KT, Raag M, Šmidt J, Semjonova S, Kogan J, Amico KR, Sharma A, Dehovitz J.

AIDS Care. 2012;24(12):1470-9. doi: 10.1080/09540121.2012.672724. Epub 2012 Apr 25.

PMID:
22533736
5.

To take or not to take: decision-making about antiretroviral treatment in people living with HIV/AIDS.

Kremer H, Ironson G, Schneiderman N, Hautzinger M.

AIDS Patient Care STDS. 2006 May;20(5):335-49.

6.

Factors associated with HIV-infected patients' recognition and use of HIV medications.

Jeffe DB, Meredith KL, Mundy LM, Fraser VJ.

J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Dec 1;19(4):350-60.

PMID:
9833743
7.

Clinical and behavioral characteristics of adults receiving medical care for HIV infection --- Medical Monitoring Project, United States, 2007.

Blair JM, McNaghten AD, Frazier EL, Skarbinski J, Huang P, Heffelfinger JD.

MMWR Surveill Summ. 2011 Sep 2;60(11):1-20.

8.

Reasons for poor adherence to antiretroviral therapy postnatally in HIV-1 infected women treated for their own health: experiences from the Mitra Plus study in Tanzania.

Ngarina M, Popenoe R, Kilewo C, Biberfeld G, Ekstrom AM.

BMC Public Health. 2013 May 7;13:450. doi: 10.1186/1471-2458-13-450.

9.

Timing of antiretroviral therapy initiation in a nationally representative sample of HIV-infected adults receiving medical care in the United States.

Adedinsewo DA, Wei SC, Robertson M, Rose C, Johnson CH, Dombrowski J, Skarbinski J.

AIDS Patient Care STDS. 2014 Dec;28(12):613-21. doi: 10.1089/apc.2014.0194.

10.

Behavioral and clinical characteristics of persons receiving medical care for HIV infection - Medical Monitoring Project, United States, 2009.

Blair JM, Fagan JL, Frazier EL, Do A, Bradley H, Valverde EE, McNaghten A, Beer L, Zhang S, Huang P, Mattson CL, Freedman MS, Johnson CH, Sanders CC, Spruit-McGoff KE, Heffelfinger JD, Skarbinski J; National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, CDC.

MMWR Suppl. 2014 Jun 20;63(5):1-22.

PMID:
24941443
11.

Delayed entry into HIV medical care in a nationally representative sample of HIV-infected adults receiving medical care in the USA.

Robertson M, Wei SC, Beer L, Adedinsewo D, Stockwell S, Dombrowski JC, Johnson C, Skarbinski J.

AIDS Care. 2016;28(3):325-33. doi: 10.1080/09540121.2015.1096891. Epub 2015 Oct 23.

PMID:
26493721
12.

Sex, Race, and HIV Risk Disparities in Discontinuity of HIV Care After Antiretroviral Therapy Initiation in the United States and Canada.

Rebeiro PF, Abraham AG, Horberg MA, Althoff KN, Yehia BR, Buchacz K, Lau BM, Sterling TR, Gange SJ.

AIDS Patient Care STDS. 2017 Mar;31(3):129-144. doi: 10.1089/apc.2016.0178. Epub 2017 Feb 27.

PMID:
28282246
13.
14.

Structural Determinants of Antiretroviral Therapy Use, HIV Care Attendance, and Viral Suppression among Adolescents and Young Adults Living with HIV.

Kahana SY, Jenkins RA, Bruce D, Fernandez MI, Hightow-Weidman LB, Bauermeister JA; Adolescent Medicine Trials Network for HIV/AIDS Interventions.

PLoS One. 2016 Apr 1;11(4):e0151106. doi: 10.1371/journal.pone.0151106. eCollection 2016.

15.

Trends in early initiation of antiretroviral therapy and characteristics of persons with HIV initiating therapy in San Francisco, 2007-2011.

Hsu LC, Truong HM, Vittinghoff E, Zhi Q, Scheer S, Schwarcz S.

J Infect Dis. 2014 May 1;209(9):1310-4. doi: 10.1093/infdis/jit599. Epub 2013 Nov 11.

PMID:
24218501
16.

Gender Differences in HIV Care among Criminal Justice-Involved Persons: Baseline Data from the CARE+ Corrections Study.

Beckwith C, Castonguay BU, Trezza C, Bazerman L, Patrick R, Cates A, Olsen H, Kurth A, Liu T, Peterson J, Kuo I.

PLoS One. 2017 Jan 12;12(1):e0169078. doi: 10.1371/journal.pone.0169078. eCollection 2017.

17.

Factors influencing treatment failure in HIV positive adult patients on first line antiretroviral therapy.

Chawana TD, Reid A, Bwakura T, Gavi S, Nhachi CF.

Cent Afr J Med. 2014 May-Aug;60(5-8):29-36.

PMID:
26867253
18.

Gender differences in antiretroviral treatment outcomes of HIV patients in rural Uganda.

Kipp W, Alibhai A, Saunders LD, Senthilselvan A, Kaler A, Konde-Lule J, Okech-Ojony J, Rubaale T.

AIDS Care. 2010 Mar;22(3):271-8. doi: 10.1080/09540120903193625.

PMID:
20390506
19.

Disparities in receipt of antiretroviral therapy among HIV-infected adults (2002-2008).

Fleishman JA, Yehia BR, Moore RD, Gebo KA, Agwu AL; HIV Research Network.

Med Care. 2012 May;50(5):419-27. doi: 10.1097/MLR.0b013e31824e3356.

20.

Factors associated with adherence to antiretroviral therapy among HIV/AIDS patients in rural China.

Wang X, Wu Z.

AIDS. 2007 Dec;21 Suppl 8:S149-55. doi: 10.1097/01.aids.0000304711.87164.99.

PMID:
18172384

Supplemental Content

Support Center